Common Fund Bets
See what stocks and ETFs funds are collectively bullish/bearish on
Largest Fund Trades
Explore the largest stock and ETF buys and sells made by funds
High Conviction Trades
Discover high conviction trades that caused a significant change in a fund's stake in a stock
Fund Manager Portfolios
Gain insights from the world’s largest funds and super investors
Price Target Consensus
See what stocks research analysts are collectively bullish/bearish on
Latest Ratings Feed
Explore the latest ratings and price targets from the best equity research analysts
Equity Analyst Profiles
Browse analysts, their latest ratings and track record
Research Firm Profiles
Browse research firm recommendations, trends, and performance
Fund Manager Index
Stock index based on fund manager consensus updated each quarter
Analyst Index
COMING SOON - Stock index based on equity analyst consensus updated every second
Sign in Sign up
BTTC

Black Titan Corp
BTTC
Market cap $24.6M

Overview Fund Trends Analyst Outlook Journalist POV
3.18 USD
-0.16
4.79%
At close Updated Dec 5, 4:00 PM EST
Pre-market
After hours
1 day
-4.79%
5 days
4.26%
1 month
-2.45%
3 months
-86.74%
6 months
-86.74%
Year to date
-86.74%
1 year
-86.74%
5 years
-86.74%
10 years
-86.74%
Upgrade to unlock
Positive
Neutral
Negative
Sentiment 3-Months
Positive
Neutral 100%
Negative

Neutral
GlobeNewsWire
24 days ago
BLACK TITAN CORPORATION APPOINTS CZHANG LIN AS CO-CHIEF EXECUTIVE OFFICER
NEW YORK, Nov. 12, 2025 (GLOBE NEWSWIRE) -- Black Titan Corporation (NASDAQ: BTTC) (the “Company” or “Black Titan”) today announced the appointment of Czhang Lin as Co-Chief Executive Officer, further strengthening the Company's leadership team as it accelerates its strategic expansion into the digital asset and blockchain sectors.
BLACK TITAN CORPORATION APPOINTS CZHANG LIN AS CO-CHIEF EXECUTIVE OFFICER
Neutral
GlobeNewsWire
2 months ago
Titan Pharmaceuticals, Inc. Announces Closing of Merger with Black Titan Corporation
NEW YORK, Oct. 03, 2025 (GLOBE NEWSWIRE) -- Titan Pharmaceuticals, Inc. (“Titan” or “TTNP”) today announced the successful closing of its previously announced merger with Black Titan Corporation (“Black Titan”) and TalenTec Sdn. Bhd. (“TalenTec”). Following the merger, the combined company's ordinary shares, $0.0001 par value per share, will trade on the Nasdaq stock exchange under the ticker symbol NASDAQ: BTTC.
Titan Pharmaceuticals, Inc. Announces Closing of Merger with Black Titan Corporation
See News Rankings
Product
Portfolios Fund Trends Large Buys & Sells Analyst Upside Analyst Price Targets Analysts Analyst Firms Stocks ETFs Sectors Industries Rankings
Resources
Plans Learn API Access
Policies
Terms & Conditions Privacy Policy Disclaimer Climate Commitment
Connect
Contact Us X (Twitter) LinkedIn

© 2025 Wall St. Rank

Sign up Sign in
Common Fund Bets See what stocks and ETFs funds are collectively bullish/bearish on Largest Fund Trades Explore the largest stock and ETF buys and sells made by funds High Conviction Trades Discover high conviction trades that caused a significant change in a fund's stake in a stock Fund Manager Portfolios Gain insights from the world’s largest funds and super investors
Price Target Consensus See what stocks research analysts are collectively bullish/bearish on Latest Ratings Feed Explore the latest ratings and price targets from the best equity research analysts Equity Analyst Profiles Browse analysts, their latest ratings and track record Research Firm Profiles Browse research firm recommendations, trends, and performance
Fund Manager Index Stock index based on fund manager consensus updated each quarter Analyst Index COMING SOON - Stock index based on equity analyst consensus updated every second

Theme